Mallinckrodt Details Development Pipeline Highlights - Quick Facts

(RTTNews) - Mallinckrodt plc (MNK) issued an update on the company's broad spectrum of near- and longer-term developmental programs for inline and investigational assets, including clinical and health economic data. The company said its aggregate net sales expectations for near-term development programs is expected to exceed $675 million at peak, with long-term development pipeline expected to exceed net sales of $1 billion at peak. Pipeline is expected to contribute above 20% of total growth long term.

Mallinckrodt also announced that the company expects four product launches over next three years.